840P - Outcomes of Advanced Renal Cell Carcinoma Patients (Arcc) Treated with First-Line Pazopanib (Paz) in a Us Community Oncology Setting
| Autor: | Vogelzang, N., Hackshaw, M.D., Hutson, T., Bhowmik, D., Yap, M., Rembert, D., Jonasch, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv292-iv292 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|